Barclays’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.82M | Buy |
515,476
+377,544
| +274% | +$2.06M | ﹤0.01% | 2001 |
|
|
2025
Q1 | $867K | Sell |
137,932
-18,335
| -12% | -$115K | ﹤0.01% | 2527 |
|
|
2024
Q4 | $643K | Buy |
156,267
+61,035
| +64% | +$251K | ﹤0.01% | 2900 |
|
|
2024
Q3 | $319K | Buy |
95,232
+61,317
| +181% | +$205K | ﹤0.01% | 3245 |
|
|
2024
Q2 | $101K | Sell |
33,915
-1,280
| -4% | -$3.81K | ﹤0.01% | 3370 |
|
|
2024
Q1 | $122K | Sell |
35,195
-28,602
| -45% | -$99.1K | ﹤0.01% | 3567 |
|
|
2023
Q4 | $86K | Buy |
63,797
+50,512
| +380% | +$68.1K | ﹤0.01% | 3747 |
|
|
2023
Q3 | $29K | Sell |
13,285
-767
| -5% | -$1.67K | ﹤0.01% | 3800 |
|
|
2023
Q2 | $34K | Buy |
+14,052
| New | +$34K | ﹤0.01% | 3837 |
|
|
2021
Q4 | – | Sell |
-100
| Closed | – | – | 3819 |
|
|
2021
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 4152 |
|
|
2021
Q2 | $0 | Buy |
+100
| New | – | ﹤0.01% | 4220 |
|
|
2020
Q3 | – | Sell |
-15
| Closed | – | – | 3915 |
|
|
2020
Q2 | $0 | Buy |
+15
| New | – | ﹤0.01% | 3952 |
|